Nothing
#' @title Reduced Piecewise Exponential Estimate/Test Software
#' @name RPEXE.RPEXT
#' @docType package
#' @description This reduced piecewise exponential survival software implements the likelihood ratio test
#' and backward elimination procedure in Han, Schell, and Kim (2012, 2014), and Han et al. (2016). Inputs
#' to the program can be either times when events/censoring
#' occur or the vectors of total time on test and the number of events. Outputs of the programs are times
#' and the corresponding p-values in the backward elimination.
#' Details about the model and implementation are given in Han et al. 2014.
#' This program can run in R version 3.2.2 and above.
#'
#'
#' @references
#' [1] Han, G., Schell, M. J., and Kim, J. (2012) “Comparing Two Exponential Distributions Using the Exact Likelihood Ratio Test," Statistics in Biopharmaceutical Research, 4(4), 348-356.
#'
#' [2] Han, G., Schell, M. J., and Kim, J. (2014) “Improved Survival Modeling in Cancer Research Using a Reduced Piecewise Exponential Approach," Statistics in Medicine, 33(1), 59-73.
#'
#' [3] Han, G., Schell, M., Zhang, H., Zelterman, D., Pusztai, L., Adelson, K., and Hatzis, C. (2016) “Testing Violations of the Exponential Assumption in Cancer Clinical Trials with Survival Endpoints," Biometrics, DOI: 10.1111/biom.12590; PMID: 27669414.
#'
#' [4] Adelson, K. B., Ramaswamy, B., Sparano, J. A., Christos, P. J., Wright, J. J., Raptis, G., Han, G., Villalona-Calero, M., Ma, C., Hershman, D., Baar, J., Klein, P., Cigler, T., Budd, T., Novik, Y., Tan, A.R., Tannenbaum, S., Goel, A., Levine, E., Shapiro, C. L., Andreopoulou, E., Naughton, M., Kalinsky, K., Waxman, S., Germain, D. (2016) “Randomized Phase II Trial of Fulvestrant Alone or in Combination with Bortezomib in Hormone Receptor-Positive Metastatic Breast Cancer Resistant to Aromatase Inhibitors: A New York Cancer Consortium Trial," Nature Partner Journals Breast Cancer, Volume 2, Article ID 16037, DOI: 10.1038/npjbcancer.2016.37.
#'
#' [5] Simon GR, Extermann M, Chiappori A, Williams C, Begum M, Haura RKE, Ismail-Khan R, Schell M, Antonia SJ, Bepler G. Phase 2 trial of docetaxel and gefitinib in the first-line treatment of patients with advanced stage non-small cell lung cancer (NSCLC) who are 70 years of age or older. Cancer 2008; 112:2021–2029.
#'
#' [6] Hatzis, C., Pusztai, L., Valero, V., Booser, D. J., Esserman, L., Lluch, A., et al. (2011). A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer. The Journal of the American Medical Association 305, 1873–1881.
NULL
#' RPEXE_fitting
#'
#' A breast cancer clinical trial dataset in Adelson et al. (2016).
#'
#' \itemize{
#' \item first column - times : time to event
#' \item second column - censor : censoring status; 0=censored, 1=event.
#' \item third column - group : labels the single agent arm and combination arm
#' }
#' @docType data
#' @keywords datasets
#' @name data2
#' @usage data(data2)
#' @references
#' [1] Adelson, K. B., Ramaswamy, B., Sparano, J. A., Christos, P. J., Wright, J. J., Raptis, G., Han, G., Villalona-Calero, M., Ma, C., Hershman, D., Baar, J., Klein, P., Cigler, T., Budd, T., Novik, Y., Tan, A.R., Tannenbaum, S., Goel, A., Levine, E., Shapiro, C. L., Andreopoulou, E., Naughton, M., Kalinsky, K., Waxman, S., Germain, D. (2016) “Randomized Phase II Trial of Fulvestrant Alone or in Combination with Bortezomib in Hormone Receptor-Positive Metastatic Breast Cancer Resistant to Aromatase Inhibitors: A New York Cancer Consortium Trial," Nature Partner Journals Breast Cancer, Volume 2, Article ID 16037, DOI: 10.1038/npjbcancer.2016.37.
NULL
#' JAMA Breast cancer
#'
#' A dataset containing predictions for chemo-censitivity and pathological response
#' from Hatzis (2011)
#'
#' \itemize{
#' \item validate: Validation status
#' \item drfs: Censoring status; 0=censored, 1=event.
#' \item drfs.time: Time to event or censoring
#' \item er.status: ER status, P=positive, N=negative
#' \item chemo.pred: Prediction for chemo sensitivity from the ACES predictor, sensitive or insensitive
#' \item pre.N: Prediction of nodal status
#' \item pCR.RD: pathological complete response (pCR) or residual disease (RD)
#' \item pre.grade: prediction of tumor grade
#' \item pre.T: T stage prediction
#' \item dlda30: DLDA30 prediction for the pathological response.
#'
#' }
#' @docType data
#' @keywords datasets
#' @name df
#' @usage data(df)
#' @references
#' [1] Hatzis, C., Pusztai, L., Valero, V., Booser, D. J., Esserman, L., Lluch, A., et al. (2011). A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer. The Journal of the American Medical Association 305, 1873–1881.
NULL
#' None Small Cell Lung cancer data
#'
#' A dataset non-small-cell lung cancer trial data from Simon et al. (2011)
#'
#' \itemize{
#' \item first column - censor : censoring status; 0=censored, 1=event.
#' \item second column - times : time to event
#' }
#' @docType data
#' @keywords datasets
#' @name simple
#' @usage data(simple)
#' @references
#' [1] Simon GR, Extermann M, Chiappori A, Williams C, Begum M, Haura RKE, Ismail-Khan R, Schell M, Antonia SJ, Bepler G. Phase 2 trial of docetaxel and gefitinib in the first-line treatment of patients with advanced stage non-small cell lung cancer (NSCLC) who are 70 years of age or older. Cancer 2008; 112:2021–2029.
NULL
#' Example data for loopcuts_cuttimes
#'
#'
#' @docType data
#' @keywords datasets
#' @name loopcuts_cut
#' @usage data(loopcuts_cut)
NULL
#' Example data for loopcut_times_censoring
#'
#'
#' @docType data
#' @keywords datasets
#' @name loopcuts_t_c
#' @usage data(loopcuts_t_c)
NULL
#' Example data for pava
#'
#'
#' @docType data
#' @keywords datasets
#' @name pava_dfrd
#' @usage data(pava_dfrd)
NULL
#' Example data for pexeest_times_censoring
#'
#'
#' @docType data
#' @keywords datasets
#' @name pexeest_times_censoring
#' @usage data(pexeest_times_censoring)
NULL
#' Example data for pexeest_tx
#'
#'
#' @docType data
#' @keywords datasets
#' @name t100
#' @usage data(t100)
NULL
#' Example data for loopcut_onestep
#'
#'
#' @docType data
#' @keywords datasets
#' @name loopcut_onestep_data
#' @usage data(loopcut_onestep_data)
NULL
#' Example data for loopcut_umbrella
#'
#'
#' @docType data
#' @keywords datasets
#' @name loopcuts_umbrella_cuttimes_mono
#' @usage data(loopcuts_umbrella_cuttimes_mono)
NULL
Any scripts or data that you put into this service are public.
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.